AUSTRALIA, Ocotber 8, 2019, (CANNABISNOW) In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression. However, peer-reviewed research into the...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness.
Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...
The potential of therapeutic cannabis is real. Since 1995, there have been over 25,000 peer-reviewed articles in various medical journals in the U.S. and around the world about the plant’s medicinal characteristics and potential for therapeutic use. Also during that time, over 30 states have approved medical cannabis programs...
U.S, February 5, 2020 (HEMPHAZETTE) (South Carolina Department of Agriculture (SCDA) announced on Friday it was to begin accepting hemp cultivation, handling and processing applications from February 1.
For the 2020 growing season, there won’t be any caps on the number of permits that...
U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
UNITED STATES, June 24, 2019 (Web MD)- Cannabidiol, or CBD, already being researched and used for anxiety, insomnia, epilepsy and pain, may be the next superbug fighter for resistant infections, a new study suggests.The researchers tested CBD against a wide variety of bacteria, ''including bacteria that have become resistant to the most commonly...